Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

267 results about "Monkeypox virus" patented technology

Monkeypox virus (MPV) is a double-stranded DNA, zoonotic virus and a species of the genus Orthopoxvirus in the family Poxviridae. It is one of the human orthopoxviruses that includes variola (VARV), cowpox (CPX), and vaccinia (VACV) viruses. But it is not a direct ancestor to, nor a direct descendant of, the variola virus which causes smallpox. Monkeypox virus causes a disease that is similar to smallpox, but with a milder rash and lower death rate. Variation in virulence of the virus has been observed in isolates from Central Africa where strains are more virulent than those from Western Africa.

Primer combination for detecting monkey pox viruses and identifying monkey pox viruses Ia, Ib and II and application

The invention discloses a primer combination for detecting monkey pox viruses and identifying monkey pox viruses Ia, Ib and II, and belongs to the technical field of molecular biology, the nucleotide sequences of specific primers and probes are shown as SEQ ID NO.1-SEQ ID NO.12, and the primer combination aims at solving the problem that in the prior art, new evolutionary branch Ib types of monkey pox viruses cannot be accurately typed, and the detection sensitivity is high. According to the present invention, the defects that the monkey pox virus and the orthopox virus have the cross reaction are overcome, the genome difference of different evolutionary branches is analyzed through the bioinformatics system, the primer probe composition capable of simultaneously detecting the monkey pox virus and carrying out accurate typing is analyzed and screened, and the primer combination can detect 200 copies / mL of the monkey pox virus with high specificity and high sensitivity. Meanwhile, detection of the monkey pox virus and identification of the types Ia, Ib and II of the monkey pox virus are realized in a reaction system, so that different monkey pox branches can be distinguished, and treatment and prevention can be performed in a more targeted manner.
Owner:KUNMING UNIV OF SCI & TECH

Nucleic acid combination, kit and method for detecting monkey pox virus based on CRISPR (clustered regularly interspaced short palindromic repeats) technology

The invention belongs to the technical field of in-vitro detection, and particularly relates to a nucleic acid combination, a kit and a method for detecting monkey pox virus based on a CRISPR (clustered regularly interspaced short palindromic repeats) technology. The detection reagent provided by the invention comprises an RPA freeze-drying reagent and a CRISPR / Cas12a detection system freeze-drying reagent, the RPA freeze-drying reagent comprises an RPA isothermal amplification reagent, Buffer A, a front primer, a rear primer and a mixed freeze-drying protective agent; the CRISPR / Cas12a detection system freeze-drying reagent comprises Cas12a, gRNA (guide ribonucleic acid), ssDNA (single-stranded deoxyribonucleic acid) reporter molecules, Buffer 2.1 and a mixed freeze-drying protective agent. The composition of the mixed freeze-drying protective agent is optimized according to the composition of a detection system and a specific detection method. The kit solves the problems of normal-temperature storage and transportation of RPA / CRISPR detection reagents of the monkey pox virus, has the characteristics of simplicity and convenience in operation, rapidness in detection, high sensitivity, suitability for on-site and large-scale screening and the like, provides an efficient and accurate solution for large-scale screening, and has a very good application prospect.
Owner:SICHUAN ACADEMY OF MEDICAL SCI SICHUAN PROVINCIAL PEOPLES HOSPITAL

RPA-Cas12a one-step detection system and application thereof

The invention relates to the field of molecular diagnosis, in particular to an RPA-Cas12a one-step detection system and application thereof. The invention finds that heparin sodium has cleavage activity for inhibiting LbCas12a, and develops a one-step nucleic acid detection method compatible with RPA amplification and Cas12 detection based on the inhibition effect. The detection limit of the method reaches 0.6 (copy / microliter), and the method can be expanded to other two Cas12 subtype proteins, namely AsCas12a and AapCas12b. In the detection of monkey pox virus, influenza A virus and new coronavirus as examples, compared with quantitative PCR, the detection sensitivity and specificity of the method both reach 95% or above. The CRISPR one-step nucleic acid detection method has the advantages of high sensitivity and specificity, short detection time and the like, and the potential nucleic acid aerosol pollution risk of a traditional two-step nucleic acid detection method is removed.
Owner:UNIV OF SCI & TECH OF CHINA

Monoclonal antibody combined with monkey pox virus B6R protein and application thereof

The invention belongs to the technical field of biological pharmacy, and particularly relates to a monoclonal antibody combined with monkey pox virus B6R protein and application of the monoclonal antibody. The antibody is any one or a combination of more of B6R-B5, B6R-F6 and B6R-F11, each of the B6R-B5, the B6R-F6 and the B6R-F11 comprises a heavy chain variable region and a light chain variable region, the heavy chain variable region has three heavy chain CDRs, and the light chain variable region has three light chain CDRs. The invention provides three groups of monoclonal antibodies with excellent affinity with the monkey pox virus B6R and disclosed heavy chain and light chain variable region sequences, provides technical support for preparing a detection and diagnosis reagent of the monkey pox virus, and is expected to be developed into a special product for screening and diagnosing the monkey pox virus. High application values are realized on prevention, control and treatment of the monkey pox virus.
Owner:ANHUI UNIV

An integrated biosensing platform based on microneedles and hydrogels and its application in detecting monkeypox virus

The present invention discloses an integrated biosensor platform based on microneedles and hydrogels and its application in detecting monkeypox virus, wherein the platform comprises a three-electrode microneedle, a hydrogel, a burning needle and a micro-electrochemical workstation. The microneedle electrode of the working electrode is combined with a nanoenzyme and an A29 protein antibody, and the monkeypox virus in the sample is extracted by the specific binding of the antibody with the monkeypox virus; the burning needle is used to connect the three-electrode microneedle and the micro-electrochemical workstation and transmit electrochemical signals. After the three-electrode microneedle is inserted into the hydrogel, the nanoenzyme catalyzes the TMB contained in the hydrogel and generates a blue oxidation product, thereby generating an electrochemical signal, which is collected by the micro-electrochemical workstation through the burning needle, and the electrochemical signal is collected through Bluetooth and a hydrogel colorimetric image is obtained, thereby realizing the detection of monkeypox virus. The integrated biosensor platform of the present invention has a low detection limit and has broad application prospects in the rapid on-site detection of monkeypox virus.
Owner:HI-SENTY (GUANGDONG) BIOTECHNOLOGY CO LTD

Above pox virus antigen epitope peptide and application thereof

The invention belongs to the technical field of immunotherapy, and particularly relates to a monkey pox virus antigen epitope peptide and application thereof. The invention aims to solve the technical problem that at present, a T cell antigen epitope peptide for universal vaccines of monkey pox viruses is not developed in the field of monkey pox viruses. According to the technical scheme of the invention, the amino acid sequence of the monkey pox virus antigen epitope peptide is shown as SEQ ID No.2. The antigen epitope peptide provided by the invention has very strong immunogenicity, and can induce antigen-specific CD8 + T cells; the antibody can be directly loaded to antigen presenting cells, can activate T cells and effectively induce T cell immunity, and can be used for research and development and preparation of universal vaccines for monkey pox viruses, research and development of drugs and clinical treatment.
Owner:THE FIRST AFFILIATED HOSPITAL OF JINAN UNIV +1

Heterocyclic aza-diketone derivative as well as preparation method and application thereof

The invention discloses a heterocyclic aza-diketone derivative as well as a preparation method and application thereof. The compound has a structure as shown in a general formula I. The invention also relates to a pharmaceutical composition containing the compound with the structure as shown in the formula I. An activity screening experiment shows that the compound disclosed by the invention has good anti-monkey pox virus activity, so that the invention also provides application of the compound in preparation of anti-monkey pox virus medicines. # imgabs0 #
Owner:SHANDONG UNIV

Antibody for resisting monkey pox virus A35R protein as well as preparation method and application thereof

The invention discloses an anti-monkey pox virus antibody as well as a preparation method and application thereof. The invention specifically discloses eight kinds of antibodies (A35R-9E4, A35R-9F8, A35R-10C4, A35R-10D5, A35R-10E7, A35R-10H6, A35R-18E2 and A35R-18H2) which have very good affinity to monkey pox virus A35R protein, and the eight kinds of antibodies have very good neutralizing activity and a certain in-vivo protection effect.
Owner:INST OF MICROBIOLOGY CHINESE ACAD OF SCI

Specific monoclonal antibody and application thereof in detection and neutralization of monkey pox virus

ActiveCN119080917Aavoid infectionInhibition of infection efficiencyImmunoglobulins against virusesAntiviralsAntigenMonkey Pox
The invention relates to a specific monoclonal antibody and application thereof. The amino acid sequence of a light chain CDR1 of the monoclonal antibody is as shown in SEQ ID No.1, the amino acid sequence of CDR2 of the monoclonal antibody is as shown in SEQ ID No.2, and the amino acid sequence of CDR3 of the monoclonal antibody is as shown in SEQ ID No.3; the amino acid sequence of a heavy chain CDR1 of the monoclonal antibody is as shown in SEQ ID No.4, the amino acid sequence of CDR2 of the monoclonal antibody is as shown in SEQ ID No.5, and the amino acid sequence of CDR3 of the monoclonal antibody is as shown in SEQ ID No.6. The recombinant monkey pox virus surface protein E8L is used as an antigen, the monoclonal antibody obtained through screening has good affinity with the recombinant monkey pox virus surface protein E8L at the molecular level and the cellular level, the infection efficiency of a VACV replication defective strain in VERO cells can be remarkably inhibited, and a good monkey pox virus in-vitro neutralization effect is achieved.
Owner:SHANGHAI JIAOTONG UNIV

Monoclonal antibody for resisting monkey pox virus M1R protein and application thereof

The invention discloses a monoclonal antibody for resisting monkey pox virus M1R protein and application of the monoclonal antibody. The invention specifically discloses a plurality of antibodies (M1R-12E10, M1R-12H5, M1R-12H6, M1R-24A7 and M1R-24H1) which have very good specificity and affinity to an M1R protein, and the antibodies have very good neutralizing activity and a certain in-vivo protection effect.
Owner:INST OF MICROBIOLOGY CHINESE ACAD OF SCI

Ultra-sensitive and high-specificity primer pair and crRNA for instantly detecting monkey pox virus, kit and application of primer pair and crRNA

The invention provides an ultra-sensitive and high-specificity primer pair and crRNA for instantly detecting monkey pox virus, a kit and application thereof, and belongs to the technical field of molecular biological detection. The primer pair and the crRNA disclosed by the invention comprise a front primer, a rear primer and the crRNA. According to the primer pair and the crRNA disclosed by the invention, immediate detection of the MIRRA-CRISPR-Cas13a mediated monkey pox virus can be realized, the detection sensitivity is high, the specificity is strong, and rapid, accurate and sensitive identification of the monkey pox virus can be realized. Through implementation, experiments show that the detection limit of the primer pair and the crRNA for detecting the monkey pox virus can reach 14.4 copies / mL, and the primer pair and the crRNA have important significance on accurate clinical diagnosis of the monkey pox virus and epidemiological investigation.
Owner:THE SECOND HOSPITAL OF NANJING

Compositions and methods for enhancement of mRNA vaccine performance and vaccination against mpox

The current disclosure includes a modular vaccine platform. Also included are monkeypox vaccines that protect against pathogenic monkeypox species, as well as their variants. The vaccines typically include a modified mRNA encoding at least one immunogen, such as a viral envelope protein, cell surface binding protein, or a biologically effective / significant fragment thereof. The mRNA can be encapsulated into lipid nanoparticles or other carriers and formulated as pharmaceutical compositions that can be used to generate an immune response to pathogens, including monkeypox virus, in a subject.
Owner:YALE UNIVERSITY

Monkey pox virus epitope mRNA composition and application thereof

The invention discloses a monkey pox virus epitope mRNA composition and application thereof, and relates to the technical field of biological medicines. The monkey pox virus epitope mRNA composition comprises mRNA encoding an epitope or an amino acid sequence having at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98% or 99% identity with the epitope and having the same immunogenicity. The vaccine can generate a high-level immune protection effect aiming at the monkey pox virus, can be used for preparing a medicine for preventing and treating the monkey pox virus, and has a wide application prospect clinically.
Owner:SHENZHEN BAY LAB +1

Immunochromatography test strip for quantitatively detecting monkey pox virus based on fluorescent latex microspheres

The invention provides an immunochromatographic test strip for quantitatively detecting monkey pox virus based on fluorescent latex microspheres, which takes europium chelate Eu (DBM) 3Phen-loaded monodisperse carboxylated polystyrene copolymer microspheres as a signal substance, and the microspheres are subjected to acid-base treatment before loading to loosen the surface structure of the microspheres so as to improve the loading capacity; the surface compound of the test strip is prepared by coupling carboxyl on the surface of the microsphere with an antibody. The invention also discloses a preparation method of the test strip. The kit is convenient for rapidly and accurately detecting the monkey pox virus, and has the characteristics of simplicity, rapidness, no toxicity and low cost.
Owner:SOUTHEAST UNIV

Antibodies against monkeypox virus h3 protein and methods of making the same

The application relates to an antibody against monkeypox virus and a preparation method thereof, and the humanized monkeypox virus antibody H3-14A7 is obtained by screening memory B cells of a human antibody against H3 specific binding mouse. The H3-14A7 has the characteristics of strong monkeypox virus binding capacity, good in-vitro neutralization, large affinity and in-vivo protection.
Owner:INST OF MICROBIOLOGY CHINESE ACAD OF SCI

Application of salinomycin in preparation of medicine for resisting monkey pox virus infection

The invention relates to the technical field of medicines, in particular to application of salinomycin in preparation of oral medicines for preventing or treating monkey pox virus (MPXV) infection. Salinomycin is a polyether antibiotic produced by actinomycetes. It is found for the first time that salinomycin can efficiently inhibit monkey pox virus infection on the cell culture level, and can significantly improve the survival rate of mice infected with monkey pox virus in small animal living bodies. More importantly, salinomycin can be administered by oral administration, has good bioavailability and safety, and provides a brand new treatment means for monkey pox virus infection. The medicinal value of salinomycin in resistance to monkey pox virus infection is reported for the first time at home and abroad, and the application prospect of salinomycin in the field of viral disease treatment is expanded.
Owner:THE NAVAL MEDICAL UNIV OF PLA

Monkey pox virus nano-vaccine based on STING agonist and silicon nano-particles as well as preparation method and application of monkey pox virus nano-vaccine

The invention relates to a monkey pox virus nano vaccine based on an STING agonist and silicon nanoparticles as well as a preparation method and application of the monkey pox virus nano vaccine. The nano vaccine comprises a monkey pox virus antigen, the silicon nanoparticles and the STING agonist, the monkey pox virus antigen is combined to the surface of the silicon nanoparticle through a DogTag-DogCatcher system; the STING agonist is connected to the surface of the monkey pox virus antigen. The monkey pox virus antigen is covalently coupled with the silicon nanoparticles, and the antigen is displayed on the surfaces of the particles in a specific spatial orientation manner, so that the multivalence and accessibility of the antigen are enhanced, the shielding effect of the silicon nanoparticles on epitopes of the antigen is reduced, and the immune response induced by the vaccine is higher than that of a monomer immunogen protein.
Owner:INSTITUTE OF PROCESS ENGINEERING CHINESE ACADEMY OF SCIENCES

Novel vaccine based on adenovirus vector and application thereof

The invention provides a novel vaccine based on an adenovirus vector and application thereof. According to the present invention, the suitable monkey pox virus gene is selected for the first time, and is efficiently integrated with the chimpanzee virus vector (AdC68) to prepare the ideal virus vaccine, and the ideal virus vaccine is suitable for nasal cavity immunization and muscle immunization, and has good nasal cavity immunization effect. The novel monkey pox vaccine can be effectively used for prevention and control of monkey pox virus and vaccinia virus infection, and the two types of viruses are considered.
Owner:SUZHOU XIANGYI BIOTECHNOLOGY CO LTD

Kit for detecting monkey pox virus based on RAA-CRISPR / Cas12a and application

The invention belongs to the technical field of biological detection, and particularly relates to a kit for detecting nucleic acid of a monkey pox virus based on RAA-CRISPR / Cas12a and a detection method. The invention provides the combination of the specific RAA primer and the specific crRNA of the monkey pox virus, the RAA technology is combined with a CRISPR-Cas12a system, the visual rapid detection of nucleic acid of the monkey pox virus is realized, and compared with the traditional method, the method has the advantages of high specificity, high sensitivity, short detection time, accurate result and the like.
Owner:SHENZHEN CUSTOMS ANIMAL & PLANT INSPECTION & QUARANTINE TECH CENT

Application of Arcyriaflavin A in preparation of medicine for preventing and treating monkey pox virus infection

The invention discloses an application of Arcyriaflavin A or a pharmaceutically acceptable salt thereof in preparation of a medicine for preventing and treating monkey pox virus infection. The invention finds that the Arcyriaflavin A can obviously inhibit the replication of the monkey pox virus in a Vero cell, and the IC50 of the Arcyriaflavin A for inhibiting the Ib branch monkey pox virus and the IC50 of the Arcyriaflavin A for inhibiting the IIb branch monkey pox virus are 0.66 mu M and 0.96 mu M respectively. The invention also verifies that the Arcyriaflavin A has extremely low toxicity to Vero cells, and the toxicity CC50 of the Arcyriaflavin A to the cells is 41.51 mu M when the Arcyriaflavin A is used for inhibiting the proliferation of the monkey pox virus, so that the Arcyriaflavin A can be used for effectively inhibiting the replication of the monkey pox virus within the safe use range of the Arcyriaflavin A. The invention provides a new choice for the prevention and treatment of monkey pox, and has important significance for the prevention and treatment of monkey pox.
Owner:THE THIRD PEOPLES HOSPITAL OF SHENZHEN

Constant isothermal sensitive detection method for detecting monkey pox virus and application

The invention belongs to the technical field of in-vitro detection, and particularly relates to a detection method for sensitively detecting monkey pox virus at constant isothermal temperature and application. The detection reagent provided by the invention comprises an RPA freeze-drying reagent and a CRISPR / Cas12a detection system freeze-drying reagent, the RPA freeze-drying reagent comprises an RPA isothermal amplification reagent, Buffer A, a front primer, a rear primer and a mixed freeze-drying protective agent; the CRISPR / Cas12a detection system freeze-drying reagent comprises Cas12a, gRNA (guide ribonucleic acid), ssDNA (single-stranded deoxyribonucleic acid) reporter molecules, Buffer 3.1 and a mixed freeze-drying protective agent. The composition of the mixed freeze-drying protective agent is optimized according to the composition of a detection system and a specific detection method. The kit solves the problems of normal-temperature storage and transportation of RPA / CRISPR detection reagents of the monkey pox virus, has the characteristics of simplicity and convenience in operation, rapidness in detection, high sensitivity, suitability for on-site and large-scale screening and the like, provides an efficient and accurate solution for large-scale screening, and has a very good application prospect.
Owner:SICHUAN ACADEMY OF MEDICAL SCI SICHUAN PROVINCIAL PEOPLES HOSPITAL +1

Poxvirus recombinant chimeric antigen, its subunit vaccine and its application

The present invention relates to a recombinant chimeric antigen targeting poxvirus (particularly monkeypox virus), a subunit vaccine thereof, and its application. The recombinant chimeric antigen of the present invention comprises two immunogens arranged in a specific manner: monkeypox virus A35 protein or its antigenic fragment (or its derivative peptide segment) and monkeypox virus M1 protein or its antigenic fragment (or its derivative peptide segment), which can stimulate immune responses against two infectious virus particles: intracellular mature virus particles (IMV) and extracellular enveloped virus particles (EEV), thereby efficiently stimulating specific immune protection against monkeypox virus. In addition, the poxvirus vaccine of the present invention also has good safety, rapid responsiveness and production capacity support, and has excellent clinical application prospects.
Owner:PEKING UNIV +3

Target spot for virtually screening anti-monkey pox virus medicine and application of target spot

PendingCN119161421AVirus peptidesDepsipeptidesVirus coreMonkey Pox
The invention provides a target spot for virtually screening an anti-monkey pox virus drug and application of the target spot, and belongs to the technical field of virtual screening of drugs. The target spot of the invention is a protein compound formed by molecular docking of MPXV F10 and VACV NPH-I; the amino acid sequence of the MPXV F10 is as shown in SEQ ID NO. 1, and the amino acid sequence of the VACVNPH-I is as shown in SEQ ID NO. 2. According to the invention, the crystal structure of the MPXV virus core protein F10 is determined, and a plurality of anti-monkey pox virus compounds are screened by virtual screening aiming at a contact cavity between the MPXV F10 and VACV NPH-I.
Owner:SHANXI MEDICAL UNIV

Method for detecting high sensitivity of monkey pox virus by one-pot RPA-CRISPR (Recombinase Polymerase Chain Reaction-Cyclic Reduced Interference Short Palindromic

The invention discloses a method for detecting high sensitivity of monkey pox virus by a one-pot method RPA-CRISPR based on temperature control, and the method comprises the following steps: establishing a temperature-controlled RPA and CRISPR-Cas12b combined detection method, which is called as CRATS for short, by utilizing the reaction temperature difference between RPA amplification and CRISPR-Cas12b cutting; the reaction process in a tube system is regulated and controlled by stages through a temperature switching strategy: target amplification is completed at 37 DEG C firstly, then the temperature is raised to 60 DEG C, Cas12b cutting is started, so that sequential separation of amplification and cutting reactions is realized, and finally detection is realized through a fluorescence signal released by molecular beacon breakage. The problem that Cas enzyme cutting activity interferes with the amplification process in a traditional one-pot method reaction is solved, the detection sensitivity and specificity are improved, and a new technical means is provided for on-site rapid detection of the monkey pox virus.
Owner:JIANGSU OCEAN UNIV

Rapid detection test paper for monkey pox virus and specific monoclonal antibody

The invention provides a monkey pox virus rapid detection test paper and a monkey pox virus specific antibody therein, the detection test paper is an immunochromatography test paper, and the detection test paper comprises a monkey pox virus specific monoclonal antibody 4C4 and a monkey pox virus specific monoclonal antibody 9D5. The monkey pox virus rapid detection test paper has good sensitivity and specificity on monkey pox viruses, and monkey pox virus detection means are perfected.
Owner:BEIJING SUBENYUANHE BIOTECHNOLOGY CO LTD

Construction method and application of monkey pox virus infected immunodeficiency mouse model

PendingCN119120589Ashort preparation timelow costHydrolasesMicrobiological testing/measurementImmunodeficient mouse modelInterferon receptor
The invention relates to a construction method and application of a monkey pox virus infected immunodeficiency mouse model, and belongs to the technical field of gene engineering and virus infection. The invention provides a construction method of a monkey pox virus infected immunodeficiency mouse model, which comprises the following steps of: knocking out interferon I, interferon II and interferon III passages by using a CRISPR / Cas9 technology, specifically knocking out a mouse I type interferon receptor IFNAR, knocking out a mouse II type interferon receptor IFNGR and knocking out a mouse III type interferon receptor IFNLR. The mouse constructed by the method disclosed by the invention has the severe condition of infection of the monkey pox virus IIb branch, and can be used for screening medicines for treating infection of the monkey pox virus IIb subtype branch.
Owner:GUANGZHOU EIGHTH PEOPLES HOSPITAL GUANGZHOU MEDICAL UNIV

Multi-antigen monkey pox RNA vaccine and preparation method thereof

The invention relates to a multi-antigen monkey pox RNA vaccine and a preparation method thereof, and relates to the technical field of nucleic acid vaccines. The multi-antigen mRNA comprises a sequence encoding an antigenic polypeptide of the monkey pox virus or an antigenic fragment, variant or derivative thereof, the antigenic polypeptide or the antigenic fragment thereof comprising at least viral proteins of an intracellular mature virus and an extracellular envelope virus of the monkey pox virus. The invention provides a multi-antigen mRNA vaccine aiming at monkey pox viruses and a sequence, mRNA can express antigen protein in in-vitro cells, high-titer anti-monkey pox virus A29L, A33L, B6R, M1R and E8L protein IgG can be detected after a mouse is immunized, a high-titer anti-vaccinia Tian Tan strain live virus neutralizing antibody is generated, good immunogenicity is achieved, and the vaccine can be used for preparing the multi-antigen mRNA vaccine aiming at the monkey pox viruses. The important significance is realized on the prevention of the monkey pox virus.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Specific monoclonal antibodies and their application in the detection and neutralization of monkeypox virus

The present invention relates to specific monoclonal antibodies and their applications. The amino acid sequence of the light chain CDR1 of the monoclonal antibody is shown in SEQ ID No. 1, the amino acid sequence of CDR2 is shown in SEQ ID No. 2, and the amino acid sequence of CDR3 is shown in SEQ ID No. 3; the amino acid sequence of the heavy chain CDR1 of the monoclonal antibody is shown in SEQ ID No. 4, the amino acid sequence of CDR2 is shown in SEQ ID No. 5, and the amino acid sequence of CDR3 is shown in SEQ ID No. 6. The present invention uses recombinant monkeypox virus surface protein E8L as an antigen. The screened monoclonal antibodies have good affinity for the recombinant monkeypox virus surface protein E8L at the molecular and cellular levels, can significantly inhibit the infection efficiency of VACV replication-deficient strains in VERO cells, and have good in vitro neutralization effect against monkeypox virus.
Owner:SHANGHAI JIAOTONG UNIV

Nucleic acid detection kit for monkey pox virus and preparation method thereof

The invention provides a monkey pox virus nucleic acid detection kit and a preparation method thereof. The kit is used for qualitatively detecting monkey pox virus nucleic acid in vitro. Specific primers and probes are designed for the target F3L gene and the internal standard RNase P gene respectively, and the primer and probe combination is excellent in specificity, stability, compatibility, anti-interference performance and instrument adaptability, high in accuracy and sensitivity, easy to operate and high in detection speed. According to the kit disclosed by the invention, a freeze-drying reagent is prepared by utilizing the primer probe, so that the kit can completely get rid of the limitation of a cold chain, convenience is provided for remote areas lacking cold chain transportation and long-distance transportation, and the transportation and storage cost is greatly reduced. The monkey pox virus nucleic acid detection kit is simple in preparation method, good in reproducibility and easy to realize large-scale production and clinical application.
Owner:SHANGHAI SHUOYING BIOTECHNOLOGY CO LTD

Monoclonal antibodies for detecting A35R protein and their applications

This invention relates to monoclonal antibodies for detecting A35R protein and their applications. This invention screened six antibodies, including antibody 4E7, antibody 11G12, antibody 6F10, antibody 6C11, antibody 18C3, and antibody 23A7. Specifically, this invention discloses the amino acid sequences of the heavy chain variable region and the light chain variable region of the above antibodies, as well as the amino acid sequences of their complementarity-determining regions and framework regions. Antibodies 4E7 and 11G12 can bind not only to the A35R-MPXV protein but also to its homologs A35R-CPXV, A35R-VTT8, and A35R-Variola. Antibodies 6F10, 6C11, 23A7, and 18C3 can specifically recognize the A35R-MPXV protein. The monoclonal antibodies described above all exhibit high binding capacity to the A35R protein, making them suitable for the sensitive and specific detection and prevention of monkeypox virus A35R protein. They can also be used clinically for the diagnosis and treatment of monkeypox virus infection-related diseases.
Owner:INST OF PATHOGEN BIOLOGY CHINESE ACADEMY OF MEDICAL SCI